Franklin Street Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Sell
5,417
-251
-4% -$14.4K 0.02% 146
2026
Q1
$344K Sell
5,668
-3,286
-37% -$192K 0.02% 125
2025
Q4
$483K Sell
8,954
-458,206
-98% -$22M 0.03% 111
2025
Q3
$21.1M Sell
467,160
-5,461
-1% -$255K 1.21% 30
2025
Q2
$21.9M Buy
472,621
+117,028
+33% +$5.74M 1.36% 28
2025
Q1
$21.7M Buy
355,593
+8,191
+2% +$477K 1.53% 23
2024
Q4
$19.6M Buy
347,402
+342,658
+7,223% +$19.1M 1.31% 26
2024
Q3
$245K Sell
4,744
-5,202
-52% -$244K 0.02% 152
2024
Q2
$413K Buy
9,946
+351
+4% +$15.7K 0.03% 115
2024
Q1
$520K Sell
9,595
-1,020
-10% -$52K 0.04% 102
2023
Q4
$545K Sell
10,615
-500
-4% -$26.2K 0.04% 96
2023
Q3
$645K Buy
11,115
+400
+4% +$24.5K 0.06% 86
2023
Q2
$685K Buy
10,715
+324
+3% +$21.7K 0.06% 86
2023
Q1
$720K Sell
10,391
-155
-1% -$10.9K 0.07% 85
2022
Q4
$759K Buy
10,546
+225
+2% +$17K 0.07% 85
2022
Q3
$734K Sell
10,321
-260
-2% -$18.9K 0.07% 87
2022
Q2
$815K Buy
10,581
+950
+10% +$72.4K 0.08% 85
2022
Q1
$703K Hold
9,631
0.06% 96
2021
Q4
$600K Sell
9,631
-575
-6% -$33.7K 0.05% 106
2021
Q3
$604K Sell
10,206
-181
-2% -$11.9K 0.05% 102
2021
Q2
$694K Sell
10,387
-2,170
-17% -$141K 0.06% 93
2021
Q1
$793K Sell
12,557
-8,583
-41% -$534K 0.07% 88
2020
Q4
$1.31M Sell
21,140
-94,832
-82% -$5.83M 0.13% 71
2020
Q3
$6.99M Sell
115,972
-65,329
-36% -$3.93M 0.75% 51
2020
Q2
$10.7M Sell
181,301
-7,653
-4% -$458K 1.27% 30
2020
Q1
$10.5M Sell
188,954
-45,151
-19% -$2.76M 1.53% 25
2019
Q4
$15M Sell
234,105
-6,619
-3% -$379K 1.78% 15
2019
Q3
$12.2M Buy
240,724
+27,731
+13% +$1.3M 1.54% 21
2019
Q2
$9.66M Sell
212,993
-36,642
-15% -$1.71M 1.24% 35
2019
Q1
$11.9M Sell
249,635
-3,241
-1% -$161K 1.66% 19
2018
Q4
$13.1M Sell
252,876
-16,501
-6% -$887K 2.08% 11
2018
Q3
$16.7M Sell
269,377
-740
-0.3% -$43.9K 2.26% 10
2018
Q2
$14.9M Buy
270,117
+31,583
+13% +$1.71M 2.18% 12
2018
Q1
$15.1M Buy
238,534
+123,995
+108% +$7.98M 2.26% 11
2017
Q4
$7.02M Buy
114,539
+3,871
+3% +$242K 1.05% 43
2017
Q3
$7.05M Buy
110,668
+36,045
+48% +$2.1M 1.16% 36
2017
Q2
$4.16M Sell
74,623
-26,835
-26% -$1.46M 0.71% 53
2017
Q1
$5.52M Sell
101,458
-15,218
-13% -$835K 0.97% 47
2016
Q4
$6.82M Buy
116,676
+3,666
+3% +$200K 1.2% 27
2016
Q3
$6.09M Sell
113,010
-4,517
-4% -$290K 1.11% 27
2016
Q2
$8.64M Buy
117,527
+578
+0.5% +$40.8K 1.64% 14
2016
Q1
$7.47M Buy
116,949
+5,142
+5% +$324K 1.48% 16
2015
Q4
$7.69M Sell
111,807
-6,460
-5% -$427K 1.51% 14
2015
Q3
$7M Sell
118,267
-11,050
-9% -$701K 1.39% 15
2015
Q2
$8.61M Sell
129,317
-8,455
-6% -$557K 1.54% 11
2015
Q1
$8.89M Buy
137,772
+1,135
+0.8% +$71.1K 1.63% 11
2014
Q4
$8.07M Buy
136,637
+975
+0.7% +$55K 1.53% 14
2014
Q3
$6.94M Sell
135,662
-5,566
-4% -$278K 1.32% 18
2014
Q2
$6.85M Sell
141,228
-10,780
-7% -$531K 1.31% 21
2014
Q1
$7.9M Sell
152,008
-17,762
-10% -$945K 1.58% 12
2013
Q4
$9.02M Sell
169,770
-1,280
-0.7% -$65.2K 1.82% 10
2013
Q3
$7.92M Sell
171,050
-1,105
-0.6% -$48.5K 1.78% 8
2013
Q2
$7.69M Buy
+172,155
New +$7.47M 1.89% 7

Other funds holding BMY

Franklin Street Advisors's BMY Position: Q2 2026 in Review

Franklin Street Advisors reduced its Bristol-Myers Squibb (BMY) stake by 4.4% in Q2 2026, selling an estimated $14.4K and leaving 5,417 shares worth $312K. The position accounts for 0.02% of the portfolio, ranked #146.

Franklin Street Advisors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $21.9M in Q2 2025. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Franklin Street Advisors held 5,417 shares of Bristol-Myers Squibb worth $312K as of Q2 2026.
  • Franklin Street Advisors sold 251 Bristol-Myers Squibb shares in Q2 2026, an estimated $14.4K.
  • Bristol-Myers Squibb made up 0.02% of Franklin Street Advisors's portfolio in Q2 2026, its #146 holding.
  • Franklin Street Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Franklin Street Advisors's Bristol-Myers Squibb position peaked at $21.9M in Q2 2025.
  • 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Franklin Street Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.